2[2]VinaykumarK,Puduvalli,Raymond,et al.Antiangiogenesis-therapeutic strategies and clinical implications for brain tumors[J].J Neurooncol,2000,50:189.
4[4]Sandstrom M,Johansson M,Andersson U,et al.The tyrosine kinase inhibitor ZD6474 inhibits tumour growth in an intracerebral rat glioma model[J].Br J Cancer,2004,91:1174.
5[5]Pavlaki M,Zucker S.Matrix metalloproteinase inhibitors (MMPIs):The beginning of phase I or the termination of phase Ⅲ clinical trials[J].Cancer Metastasis Rev,2003,22:177.
6[6]Rundhaug JE.Matrix metalloproteinases and angiogenesis[J].J Cell Mol Med,2005,9:267.
7[7]Kumar S,Witzig TE,Rajkumar SV.Thalidomide as an anti-cancer agent[J].J Cell Mol Med,2002,6:160.
8[8]Steven KT.Properties of Thalidomide and its analogues:implications for anticancer therapy[J].The AAPS Journal,2005,7:14.
9[9]Vincent L,Kermani P,Young LM,et al.Combretastatin A4 phosphate induces rapid regression of tumor neovessels and growth through interference with vascular endothelial-cadherin signaling[J].J Clin Invest,2005,115:2992.
10[10]Flenke FM,Gebhard MM,Ewerbeck V,et al.The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors:an intravital microscopy study in mice[J].BMC Cancer,2006,6:9.
二级参考文献1
1S. Gail Eckhardt,James M. Pluda. Development of angiogenesis inhibitors for cancer therapy[J] 1997,Investigational New Drugs(1):1～3
6Yamada M, Ohnishi J, Ohkawara B, et al. NARF, an Nemo-likeKinase ( NLK ) -associated Ring Finger Protein Regulates theUbiquitylation and Degradation of T Cell Factor/LymphoidEnhancer Factor(TCF/LEF) [ J]. J Biol Chem,2006,281 :20749.
7Nielsen 0, Bjerrum J, Csillag C, et al. Influence of smoking oncolonic gene expression profile in Crohn s disease [ J ]. PLoS One,2009,4:6210.
